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INTRODUCTION:	A	BRIEF	OVERVIEW	ABOUT	ACUTE	
MESENTERIC	ISCHEMIA		Acute	 Mesenteric	 Ischemia	 (AMI)	 is	 a	 condition	 due	 to	 inadequate	 blood	 flow	support	and	oxygen	delivery	to	meet	the	metabolic	demands	of	the	visceral	organs	resulting	 in	 ischemia	 and	 eventually	 gangrene	 of	 the	 bowel	 wall.	 Although	considered	 relative	 rare,	 it	 is	 a	 potentially	 life-threatening	 condition	 if	 not	 early	identified	and	properly	treated.		
EPIDEMIOLOGY	Among	 hospital	 admissions	 for	 abdominal	pain,	 overall	 AMI	 prevalence	 is	 attested	around	 0,1%.	1 	However	 it	 may	 increase	exponentially	 in	 elderly	 and	 people	 with	risk	 factors	 and	 comorbidities	 for	cardiovascular	 disease.2,3	In	 a	 population-based	study	in	Sweden,	Acosta	et	al.	found	an	exponential	 increase	of	AMI	 incidence	with	age	reaching	a	peak	of		217	per	100,000	person	years	in	the	age	category	of	85	and	above	.4			Aetiological	 distribution	 has	 reported	 to	 be	 60-70%	 for	 occlusive	 mesenteric	ischemia	(OMI),	20-30%	for	non	occlusive	mesenteric	ischemia	(NOMI),	10-18%	for	venous	mesenteric	thrombosis,	2-3%	other	causes.	(see	Figure	1)5	No	 clear	 gender	 predominance	 has	 been	 found	 and	male-to-female	 ratio	 for	 AMI	varies	widely	among	population-based	studies.	6,7					
Figure	1	Distribution	of	etiologies	in	patients	with	acute	mesenteric	ischemia	in	Malmö,	Sweden	between	1970	and	1982,	when	autopsy	rate	was	87%.	SMA,	superior	mesenteric	artery.	5	
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A	matter	of	concern	for	a	so	rare	disease	is	the	high	mortality	rate	attested	around	60-90%.8,9	It	 seems	 to	be	 related	not	 only	 to	 the	 intrinsic	 severity	 of	 the	 ischemic		damage	to	gut	mucosae,	but	also	to	a	delayed	diagnosis	due	to	a	non-specific	clinical	presentation	and	a	“watch	and	see”	approach	in	elderly	with	abdominal	pain.	10,11			
	ANATOMICAL	INSIGHT	The	knowledge	of	the	mesenteric	circulation	is	essential	to	understand	the	physio-pathological	implications	of	acute	mesenteric	ischemia.		Three	 are	 the	 main	 arterial	 vessels	 that	 supply	 foregut,	 midgut	 and	 hindgut:	 the	celiac	axis,	the	superior	mesenteric	artery	(SMA),	and	the	inferior	mesenteric	artery	(IMA)	respectively.		The	celiac	axis	arises	from	the	ventral	surface	of	the	aorta	at	the	T12-L1	vertebral	body.	 It	 courses	 antero-inferiorly	 before	 branching	 into	 the	 common	 hepatic,	splenic,	and	left	gastric	arteries.	Many	possible	variations	are	described.	12	The	 SMA	 comes	 off	 the	 ventral	 aorta	 and	 supplies	 the	 midgut	 by	 giving	 off	 the	inferior	 pancreaticoduodenal	 artery,	middle	 colic,	 right	 colic,	 and	 jejunal	 and	 ileal	branches.	The	inferior	mesenteric	artery	(IMA)	arises	from	the	aorta	at	L3-L4	level.	The	first	branch	 is	 the	 left	 colic	 artery.	 There	 are	 multiple	 other	 smaller	 branches	 of	 the	artery	 that	 give	 off	 descending	 colic	 and	 sigmoid	 branches.	 The	 superior	 rectal	artery	is	the	terminal	branch	and	has	right	and	left	branches.13	
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The	 interconnection	between	 these	vessels	 is	made	of	many	collateral	vessels	and	anastomosis,	most	 of	which	 are	 functional	 thus	 activated	 in	 case	 of	 necessity	 (fro	example	poor	blood	supply).	The	main	are:		
• The	 pancreato-duodenal	 arcade	 connects	 the	 celiac	 axis	 (superior	pancreatoduodenal	 arcade)	 to	 the	 superior	 mesenteric	 artery	 (inferior	pancreatoduodenal	arcade);		
• The	dorsal	pancreatic	artery	that	has	its	origin	from	the	SMA	is	important	in	collateral	circulation	between	the	SMA	and	celiac	axis;	
• The	Arc	of	Buhler	connects	the	celiac	axis	and	SMA	vertically	and	ventral	to	the	aorta;	
• The	 Arc	 of	 Barkow	 also	 connects	 the	 celiac	 axis	 and	 SMA	 through	 an	anastomosis	of	the	right	gastroepiploic	artery	and	left	gastroepiploic	artery.	It	assists	in	supplying	the	transverse	colon;	
• The	Marginal	artery	of	Drummond	connects	the	SMA	and	IMA.	This	collateral	vessel	 is	 formed	 by	 the	 terminal	 branches	 from	 the	 SMA	 (ileocolic	 artery,	right	colic	artery,	left	colic	artery)	and	the	IMA	(left	colic	artery	and	sigmoid	arteries);		
• The	 Arc	 of	 Riolan,	 also	 known	 as	 the	 mesenteric	 meandering	 artery,	 also	connects	the	SMA	and	IMA.	I	The	classic	collateral	pathway	of	this	vessel	con-	nects	the	middle	colic	artery	to	the	left	colic	artery		
Finally	 the	 superior	 rectal	 artery,	 which	 is	 a	 branch	 of	 the	 IMA,	 and	 the	 inferior	rectal	artery,	which	is	a	branch	of	the	internal	iliac	arteries,	may	provide	collaterals	between	these	two	circulatory	pathways.	14	
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PATHOPHYSIOLOGY	As	mentioned	 above,	AMI	 is	 due	 to	 an	 impairment	between	blood	 supply	 and	gut	tissue	demands.	This	condition	 is	 the	result	of	an	obstruction	or	diminished	blood	support	 of	 the	 arterial	 system	 or	 an	 outflow	 reduction	 of	 the	 mesenteric	 veins	system.	15		When	 oxygen	 delivery	 and	 extraction	 capacities	 is	 below	 tissue	 demands,	 the	ischemic	 injury	of	 the	visceral	organs	determines	 local	and	systemic	 inflammatory	pathways.16		Vasodilatation,	due	mainly	to	inducible	nitric	oxide	release,	is	the	first	response,	but	prolonged	ischemia	 leads	to	 inflammatory	cells	activation	producing	cytokines,	platelet	activating	factors,	leukotriene	and	toxic	free	oxygen	radicals.	17,18	Leukocyte	adhesion,	platelet	aggregation	and	nitric	oxide	increase	the	damage	of	the	intestinal	 microcirculation. 19 	Toxic	 free	 oxygen	 radicals,	 that	 damage	 the	 cell	membrane	through	lipid	peroxidation,	cause	an	increase	in	capillary	permeability.20	Progressive	 interstitial	 imbibition	 reduces	 oxygen	 extraction	 from	blood	 flow	 and	causes	 vasoconstriction	 that	 can	 be	 maintained	 even	 after	 intestinal	 blood	 flow	returns	 to	 normal.21	Intestinal	mucosa	 and	 sub-mucosa	 are	 the	 first	 target	 of	 this	insult	resulting	in	a	reduced	capacity	to	prevent	bacterial	translocation	from	bowel	lumen	to	systemic	blood	flow.22	Consequently,	 if	not	reversed,	 ischemic	 insult	may	lead	to	full-thickness	injury,	infarction	and	then	necrosis	of	the	bowel.	Furthermore	systemic	bacteremia	and	septic	state	is	established	causing	multi-organ	failure	and	death.23		Collateral	vessels	and	anastomosis	can	be	activated	but	it	may	take	several	days	or	weeks.	 Thus	 in	 case	 of	 slowly	progressing	mesenteric	 atherosclerosis	 they	 can	be	already	 fully	 developed	 and	 provide	 a	 source	 of	 blood	 supply	 even	 in	 case	 of	
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thrombotic	stenosis.	Conversely,	in	case	of	abrupt	arterial	occlusion	such	as	caused	by	 emboli,	 collateral	 vessels	 are	 useless	 in	 the	 first	 hours	 so	 that	 they	 cannot	prevent	ischemic	insult	to	gut	tissue.	24		
CLASSIFICATION	AND	CLINICAL	PRESENTATION	AMI	is	classified	as:	Occlusive	Mesenteric	 Ischemia	(OMI)	that	 is	result	of	an	acute	arterial	 vessel	occlusion	due	 to	 thrombosis	or	 embolus;	Non-Occlusive	Mesenteric	Ischemia	(NOMI)	caused	by	reduced	arterial	blood	support	due	to	reduced	cardiac	output,	 shock	 state	 or	 arteriolar	 vasoconstriction	 of	 the	 mesenteric	 vessels	 itself	without	stenosis	of	the	main	artery;	Mesenteric	Venous	Thrombosis	(MVT)	caused	by	 venous	 thrombosis	 causing	 outflow	 impairment	 and	 increase	 of	 the	 capillaries	pressure.	 An	 non-acute	 form	 is	 called	 Chronic	 Mesenteric	 Ischemia	 (CMI)	 or	Ischemic	colitis	(IC)	due	to	progressive	arterial	atherosclerosis	that	 is	 the	cause	of	abdominal	angina.			
Occlusive	Mesenteric	Ischemia	(OMI)		Arterial	 obstruction	 is	 considered	 the	most	 common	 cause	 of	 mesenteric	ischemia.		Embolic	 occlusion	 is	 attested	 around	40-50%	 of	 cases	 whilst	 thrombotic	occlusion	 of	 a	 previously	 stenotic	mesenteric	 vessel	 around	 20-35%.	Other	 causes,	 such	 as	 artery	 dissection	 or	 vasculitis,	 represent	 less	 than	 5%	 of	cases.25	
Figure	2	Principal	sites	of	occlusion	of	the	superior	mesenteric	artery	
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The	most	common	embolic	source	is	from	the	heart	and	atrial	 fibrillation,	valvular	disease	or	prior	myocardial	 infarction	are	commonly	seen	 in	 these	patients.	26	The	embolus	 may	 occlude	 the	 arterial	 lumen	 completely	 or	 partially.	 Emboli	 tend	 to	lodge	at	points	of	normal	 anatomical	narrowing,	usually	 immediately	distal	 to	 the	origin	of	a	major	branch.	Typically,	 the	embolus	 lodges	a	 few	centimeters	distal	 to	the	 origin	 of	 the	 SMA,	 sparing	 the	 proximal	 jejunal	 branches,	 and	 allowing	preservation	 of	 the	 proximal	 jejunum.	 (see	 Figure	 2)	 Clinically	 this	 condition	 is	characterized	 by	 an	 abrupt	 onset	 of	 severe	 abdominal	 pain	 “out	 of	 proportion	 to	clinical	signs”,	sometimes	associated	with	diarrhea	and/or	hematochezia.		Most	part	of	 the	 small	 bowel	 and	 right-side	 of	 the	 colon	 suffers	 from	 severe	 ischemia	 and	usually	the	treatment	is	bowel	resection	of	the	ischemic	segment.27					Thrombotic	stenosis	and	occlusion	of	the	arterial	mesenteric	vessels	is	responsible	for	 approximately	 25%	 of	 AMI	 cases.	 Superior	 mesenteric	 artery	 is	 the	 most	involved	vessel	in	atherosclerotic	plaque	formation	and	stenosis,	often	at	its	origin.	Thus	 ischemia	 usually	 develops	 from	 proximal	 jejunum	 to	 mid	 transverse	 colon.	Narrowing	 of	 the	 SMA	has	 the	 greatest	 impact	 on	 the	 development	 of	mesenteric	ischemia.	28	Celiac	axis	and	inferior	mesenteric	artery	are	less	involved,	probably	for	their	 different	 angle	 origin	 from	 the	 aorta.	 Collateral	 vessels	 may	 be	 present,	consistent	 with	 an	 acute	 worsening	 of	 an	 underlying	 chronic	 condition.	 This	condition	determines	a	less	abrupt	onset	of	thrombotic	AMI	than	embolic	AMI.29		More	than	90%	of	cases	of	chronic	mesenteric	 ischemia	are	related	to	progressive	atherosclerotic	disease	that	affects	the	origins	of	the	visceral	vessels.	Some	of	these	patients	may	have	 a	 known	 atherosclerosis	 involvement	 in	 other	 vascular	 district	and	risk	factors	for	cardiovascular	events.	30		
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Non-Occlusive	Mesenteric	Ischemia	(NOMI)	Non-occlusive	mesenteric	ischemia	is	approximately	responsible	for	20-30%	of	AMI	cases.		This	condition	is	typically	the	result	of	a	prolonged	state	of	hypotension	due	to	 low	 cardiac	 output	 and/or	 shock	 states.	 In	 order	 to	 preserve	 vital	 organ	perfusion,	 blood	 flow	 is	 redistributed	 through	 arteriolar	 mesenteric	 vessels	vasoconstriction	 causing	 severe	 intestinal	 hypoperfusion	 despite	 the	 mesenteric	arteries	being	patent.31,32	Furthermore	vasoactive	drugs,	inotropes,	digoxin	and	beta	blocker	have	been	associated	with	arteriolar	vasoconstriction.	33,34		The	diagnosis	of	NOMI	 can	 be	 extremely	 challenging	 as	 symptoms	 are	 subtle	 and	 non-specific.	Critically	 ill	 patients	 such	 as	 those	mechanically	 ventilated	 and/or	 post-operative	from	major	 surgery	 (especially	 cardiac	 or	 aortic	 surgery)	 are	more	 predispose	 to	develop	this	condition.					
Mesenteric	Venous	Thrombosis	(MVT)			Mesenteric	 venous	 thrombosis	 accounts	 for	 10-18%	 of	 all	 AMI	 cases	 with	 an	incidence	of	2.7	per	100.000	person-years.	 	However	 its	prevalence	has	 increased	over	 the	 last	 decades.	 35 	When	 a	 thrombotic	 event	 of	 the	 porto-mesenteric	circulation	occurs,	 the	 venous	 return	 from	 the	bowel	 is	 compromised	 resulting	 in	mesenteric	venous	hypertension.	 	The	outflow	 impairment	will	 lead	 to	bowel	wall	ischemia,	 further	worsened	 by	 a	 reactive	 arterial	 spasm,	 and	 full	 thickness	 bowel	wall	 damage.	36	Predisposing	 factors	 to	MVT	 are	 cirrhosis,	 hypercoagulable	 states,	local	 anatomical	 alteration	 that	 may	 contribute	 to	 venous	 outflow	 impairment.37	Clinically,	 acute	mesenteric	 venous	 thrombosis	 is	 characterized	 by	 acute	 onset	 of	
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abdominal	pain	within	24-72	hours	even	though	in	10-15%	of	cases	a	more	subtle	presentation	is	described	with	non-specific	symptoms.	38	
DIAGNOSTIC	WORKUP	A	critical	concept	is	that	AMI	diagnosis	should	be	driven	by	“clinical	suspicion”	and	everything	should	be	done	as	soon	as	possible	to	confirm	or	rule	out	the	diagnosis.		
Laboratory	Tests		Laboratory	tests	are	of	little	help	in	the	diagnosis	of	AMI	as	no	specific	biomarkers	for	bowel	ischemia	has	been	found.39	Patients	with	AMI	have	been	found	having	leucocytosis,	metabolic	acidosis,	elevated	acid	lactate	and	D-dimer	but	none	of	them	seem	too	specific.	40	About	the	latter,	for	its	high	negative	predictive	value,	Acosta	et.	al	suggested	that	it	may	be	used	as	an	exclusion	 test	 only	 if	 arterial	 occlusion	 is	 unlikely.	41	Over	 the	 past	 decades,	 new	biomarkers	 such	 as	 alpha-glutathione	 S-transferase	 (GST)	 and	 intestinal	 plasma	fatty	 acid–binding	 proteins	 (FABPs)	 were	 also	 investigated.	 GST	 and	 FABPs	sensitivity	for	AMI	ranged	from	20%	to	100%	and	from	64%	to	100%	respectively	but	they	are	not	so	widespread	among	Emergency	setting.42,43		
Imaging	Nowadays,	 multi	 detector	 computed	 tomography	 (MDCT)	 of	 the	 abdomen	 with	contrast	enhancement	for	arterial	and	venous	phase	(CTA),	has	become	the	test	of	choice	 to	 investigate	 AMI	 replacing	 conventional	 angiography. 44 	Both	 arterial	occlusion	and	venous	 thrombosis	can	be	evaluated	as	well	as	bowel	wall	 ischemic	insult.	 	 It’s	 sensitivity	 and	 specificity	 are	 attested	 around	 90-97%	 and	 93-97%	respectively.	 45 	Furthermore	 its	 diagnostic	 accuracy	 can	 be	 improved	 if	 the	
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radiologist	 is	 aware	 about	 the	 clinical	 suspicion	 of	 AMI	 as	 some	 of	 the	 signs	 are	subtle	 and	 can	 be	 overlooked.	46,47	Decreased	 or	 absent	 bowel	 wall	 enhancement	and	pneumatosis	are	probably	the	most	specific	CT	signs	of	AMI	even	if	effected	by	poor	 sensitivity	 (16-62%).48	Conversely	 other	 signs	 like	 bowel	 wall	 thickening,	mesenteric	 fat	 stranding,	 luminal	 dilatation	 are	more	 commonly	 present	 but	 less	specific.	 One	 of	 the	 main	 limitation	 of	 this	 technique	 is	 the	 necessity	 of	 contrast	enhancement,	 if	not	used	the	diagnostic	accuracy	 is	 far	 less	and	can	even	 increase	AMI	 mortality.	 49 	Finally	 the	 risk	 related	 to	 radiation	 exposure	 has	 to	 be	considered.50	
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Catheter-based	arteriography	maintains	the	role	of	the	gold-standard	in	diagnosing	overall	arterial	occlusion.	Anyway,	for	its	invasive	nature,	it	is	considered	a	second	level	diagnostic	 test	after	CTA.	Other	 than	diagnostic	 feature,	 it	can	support,	when	indicated,	endovascular	intervention	and	treatment.	51				
The	role	of	other	imaging	diagnostic	technique	is	limited:	abdomen	X-ray	is	poorly	sensible	and	 if	AMI	 signs	are	present	 (pneumatosis,	pneumobilia,	perforation)	 the	ischemic	 damage	 is	 well	 established	 with	 little	 chance	 to	 revert	 it;	 magnetic	resonance	with	Gadolinium	contrast	enhancement	is	able	to	detect	vessels	occlusion	but	 with	 less	 accuracy	 than	 CT-A	 and	 the	 longer	 execution	 time	 and	 availability	reduce	its	utilization	in	acute	setting.	52,53				
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TREATMENT:	A	“TIME	DEPENDENT”	APPROACH	Treatment	strategies	differ	on	the	basis	of	etiological	category,	thus	is	important	to	properly	identify	the	type	of	AMI.	Furthermore	it	is	important	to	establish	whether	transmural	 bowel	 necrosis	 has	 already	 occurred	 and	 if	 signs	 of	 peritonitis	 are	present.		
An	 emerging	 concept	 is	 that	 the	 soon	AMI	 is	 confirmed	 and	properly	 treated,	 the	better	 is	 the	 outcome.	 9,54,55Like	 all	 others	 vascular	 ischemic	 disease,	 there’s	 a	continuum	from	vascular	occlusion/stenosis,	reduced	blood	flow,	an	early	phase	of	tissue	reversible	insult	and	finally,	if	not	resolved,	irreversible	damage	and	necrosis	will	be	established.	In	recent	years,	studies	reported	a	reduction	in	mortality	to	less	than	 30%	when	 treatment	 is	 begun	within	 6-8	 hours	 after	 symptoms	 onset,	 thus	AMI	can	be	considered	a	time-dependent	disease.	56,57	
Therapeutic	Strategies	for	OMI				In	 hemodynamically	 stable	 patients	 and	 without	 signs	 of	 peritonitis,	 after	 CTA	confirmation	 of	 OMI,	 endovascular	 therapy	 should	 be	 attempted	 before	revascularization	 as	 the	 primary	 revascularization	 method.	 58 	The	 aim	 of	 this	technique	is	aspiration	thrombectomy	in	case	of	emboli	or	stent	application	in	case	of	atherosclerotic	occlusion.	Another	viable	option	in	case	of	 incomplete	thrombus	aspiration	 or	 distal	 embolization	 is	 catheter	 directed	 thrombolysis,	 usually	 with	recombinant	tissue	plasminogen	activator.	59	Nowadays	aspiration	thrombectomy	is	considered	the	method	of	choice	because	reperfusion	can	be	achieved	quicker	than	thrombolic	agent	infusion.	60	If	endovascular	approach	is	unsuccessful	or	unfeasible,	open	surgical	embolectomy	or	vascular	bypass	is	the	alternative.	61	
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In	 case	 of	 CTA	 findings	 of	 transmural	 bowel	 damage,	 clinical	 signs	 of	 peritonitis	along	with	metabolic	acidosis	and	severe	hyperlactatemia,	reflection	of	a	prolonged	state	of	ischemia,	then	open	laparoscopy	for	extensive	bowel	resection	become	the	first	line	approach.62	
Therapeutic	Strategies	for	NOMI		As	 NOMI	 reflects	 a	 state	 of	 bowel	 tissue	 hypoperfusion	without	mesenteric	main	vessels	occlusion,	treatment	should	seek	to	reverse	the	underlying	cause.	Thus	fluid	resuscitation,	 oxygen	 administration,	 correction	 of	 anemia,	 optimization	 of	electrolyte	balance,	antibiotic	and	low	molecular	weight	heparin	(LMWH)	represent	the	first	line	treatment.	Vasoactive	agents	and	other	medications	causing	mesenteric	arteriolar	vasoconstriction	should	be	avoided	or	suspended.	63		If	bowel	necrosis	is	already	 established,	 laparoscopy	 for	 surgical	 resection	 should	 be	 considered.	64,65	Experimental	treatments	have	attempted	intra-arterial	infusion	of	vasodilator	drugs	like	papaverine,	prostaglandine	and	iloprost	reporting	encouraging	but	still	limited	results.		66	
Therapeutic	Strategies	for	MVT		In	case	of	non-complicated	porto-mesenteric	venous	thrombosis,	first	line	treatment	is	 simple	 anticoagulation	 with	 LMWH	 and	 continued	 with	 oral	 anticoagulant.	 If	bowel	 transmural	damage	 is	clinically	suspected	(signs	of	peritonitis)	or	 there	are	evidences	at	CTA	imaging,	then	continuous	unfractionated	heparin	infusion	should	be	preferred	both	for	a	better	monitoring	of	the	anticoagulation	level	and	the	chance	to	be	reversed	with	protamine	if	surgery	is	required.		67	
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Endovascular	treatment	which	includes	mechanical	thrombectomy	and/or	catheter-directed	thrombolysis	via	trans-hepatic	or	trans-jugular	porto-systemic	access	may	be	considered.	68																				
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DUPLEX	ULTRASOUND	(DUS)	AND	ACUTE	MESENTERIC	ISCHEMIA	Duplex	 ultrasonography	 (DUS)	 has	 been	 used	 in	 the	 diagnosis	 of	 mesenteric	vascular	 disease.	 It	 can	 reliably	 detect	 arterial	 occlusion/stenosis	 and	 venous	thrombosis	of	 the	main	vessels	as	well	 as	bowel	wall	 thickness	and	enhancement,	abdominal	 free	 fluid,	 hypotonic	 reflex	 ileus	 or	 paraliticus	 ileus.	69	Moreover	 it	 is	widely	 available,	 reproducible,	 relatively	 inexpensive	 and	 without	 radiation	exposure	risk.	However	it	is	operator	dependent	and	it’s	application	can	be	limited	by	the	presence	of	bowel	gas	and	respiratory	movements.		Nowadays	it’s	application	is	mainly	pointed	towards	the	study	of	chronic	mesenteric	ischemia	 and	 to	 assess	 patients	 after	 major	 cardiovascular	 surgery	 experiencing	abdominal	 complains.	 Unfortunately,	 few	 are	 the	 studies	 assessing	 the	 feasibility	and	diagnostic	accuracy	of	DUS	in	acute	settings.	70		
MESENTERIC	ARTERIES	ASSESSMENT						DUS	of	 the	mesenteric	vessels	 is	usually	performed	with	a	3,5-5	Mhz	probe,	using	grey-scale	 B-mode,	 color	 and	 doppler	 analysis	 using	 an	 angle	 of	 60°	 to	 assess	arterial	velocities	with	a	sample	volume	of	1,5mm.	Doppler	analysis	consists	of	the	evaluation	of	the	“doppler	shape”	of	the	trace,	the	measurement	of	the	peak	systolic	velocity	 (PSV)	 and	 the	 end	 diastolic	 velocity	 (EDV).	 High	 PSV	 and	 EDV	 correlates	with	 arterial	 stenosis	whilst	 low	 values	may	 reflect	 systemic	 hypotensive	 state.	71		The	 resistive	 index	 (RI)	 calculated	 with	 the	 following	 formula:	 (peak	 systolic	velocity	 –	 end	 diastolic	 velocity)/	 peak	 systolic	 velocity,	 is	 derived	 to	 assess	 the	relationship	between	PSV	and	EDV.	RI	 values	 lower	 than	0.70	 reflect	 a	 significant	increase	of	the	arteriolar	resistance.	72	
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Celiac	 axis	 is	 generally	 best	 accomplished	 in	 the	 sagittal	 plane,	 whereas	 its	 main	branches	 (common	 hepatic,	 splenic,	 and	 left	 gastric	 arteries)	 are	 best	 seen	 in	 the	trans-	verse	view.	Its	classical	ultrasound	visualization	of	the	T-	shaped	bifurcation	(seagull	sign)	on	the	transverse	view	is	a	characteristic	landmark.	Doppler	tracing	is	usually	biphasic	with	high	diastolic	velocities	reflecting	a	low	resistance	circulation	to	 liver	and	spleen.	PSV	and	EDV	normal	values	are	 reported	 to	be	80-100cm/sec	and	 30-65cm/sec	 respectively.73	PSV	 >200cm/sec	 and	 EDV>55cm/sec	 correlates	with	a	stenosis	>70%	.	74	SMA	is	best	seen	in	sagittal	view	of	 the	upper	midline	abdomen,	 it	arises	 from	the	anterior	aspect	of	the	aorta	then	travelling	inferiorly	1cm	below	celiac	axis.	Doppler	tracing	 is	 triphasic	with	higher	PSV	and	 lower	EDV	 than	 celiac	 axis.	 PSV	and	EDV	normal	values	are	considered	80-200cm/sec	and	20-40	cm/sec	respectively.	75	PSV	>400cm/sec	and	EDV>70cm/sec	correlates	with	a	stenosis	of	>70%.76	IMA	comes	off	the	aorta,	just	above	its	bifurcation	into	the	common	iliac	arteries,	in	an	 anterior	 lateral	 orientation.	 As	 it	 is	 thinner	 than	 the	 other	mesenteric	 arteries	and	usually	covered	by	small	bowel,	it	is	really	difficult	to	assess	with	DUS.77	
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PORTO-MESENTERIC	VENOUS	ASSESSMENT	Portal	vein	(PV)	and	superior	mesenteric	vein	(SMV)	occlusion	causes	 impairment	in	the	intestinal	vein	drainage	with	consequent	vascular	engorgement,	swelling,	and	hemorrhage	of	the	bowel	wall,	with	extravasation	of	fluid	from	the	bowel	wall	and	mesentery	 into	 the	 peritoneal	 cavity.	 If	 not	 resolved,	 venous	 occlusion	 causes	mucosal	 edema	 and	 punctate	 hemorrhage	 that	 progress	 to	 widespread	hemorrhages.	 Progression	 of	 the	 thrombosis	 and	 inadequate	 collateral	 circulation	leads	to	infarction	of	the	jejunum	and	the	ileum.78			DUS	may	reveal	thrombus	at	the	PV	and/or	SMV	if	color-mode	is	absent	and	no	flow	is	shown	at	Doppler	tracing.	79		
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BOWEL	ASSESSMENT	In	 late	 phases	 of	 AMI,	 when	 the	 ischemic	 damage	 is	 already	 established	 causing	transmural	 necrosis,	 DUS	 may	 be	 useful.	 Normal	 bowel	 wall	 appearance	 to	ultrasound	 is	 made	 of	 five	 layers	 of	 alternating	 concentric	 hyperechoic	 and	hypoechoic	 bands	 with	 a	 wall	 thickness	 <4mm	 and	 the	 presence	 of	 color/power	mode.	80	Homogeneously	 hypoechoic	 intestinal	 wall	 as	 a	 result	 of	 edema	 and	 increased	intraluminal	 secretions	 within	 the	 involved	 segments	 that	 occurs	 earlier	 in	 the	course	of	AMI	can	be	detected	with	DUS.	Furthermore	decreased	peristalsis,	mural	thickening	 of	 the	 involved	 segment	 (>4mm),	 intraperitoneal	 gas,	 and	 peritoneal	fluid	 can	 be	 detected	 in	 late	 phase.81 	However	 the	 most	 specific	 findings	 for	mesenteric	 ischemia	 are	 intramural	 gas,	 portal	 system	 gas	 and	 reduced	 color	 or	power	mode	of	the	bowel	walls.	82These	findings	will	be	observed	in	those	intestine	segments	involved	by	the	ischemic	insult.	
	 20	
THE	RESEARCH	PROJECT	
AIM	OF	THE	PROJECT	Early	 diagnosis	 and	 treatment	 are	 the	 key	 points	 to	 reduce	 mortality	 of	 AMI.83	Abdomen	CTA	is	considered	the	radiological	test	of	choice	to	confirm	the	diagnosis,	however	 “clinical	 suspicious”	 remains	 the	 most	 important	 feature	 to	 drive	 the	diagnostic	 workup	 as	 presenting	 signs	 and	 symptoms	 are	 non-specific.	84	Time-consuming	use	of	inappropriate	diagnostic	procedures	and/or	wait-and-see	attitude	remains	the	main	causes	of	delayed	diagnosis.	85		
Thus	 a	 new	 approach	 to	 correctly	 identify	 AMI	 among	 those	 patients	 presenting	acute	abdominal	pain	of	unknown	origin	should	be	sought.	In	other	clinical	scenario	with	similar	feature	of	uncertainty,	where	an	early	and	specific	diagnosis	is	required	to	 promptly	 start	 an	 appropriate	 treatment,	 like	 for	 those	 patients	 querying	pulmonary	 embolism,	 clinical	 diagnostic	 tools	 (CDTs)	 have	 been	 created.86	To	 our	knowledge,	only	one	diagnostic	scoring	model	has	been	purposed	by	Wang	et	al.	for	AMI,	however	it	was	done	on	a	small	population	with	strict	inclusion	criteria,	based	only	 on	 laboratory	 test	 investigations	 and	 not	 yet	 verified. 87 	(see	 Figure	 3)	
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Figure	3	The	scoring	model	system	suggested	by	Wang	et	al.	for	the	diagnosis	of	acute	mesenteric	ischemia.	A	result	of	>4	would	have	97.8%	and	91.8%	of	sensitivity	and	specificity	respectively		Furthermore	 there	 are	 little	 data	 about	 the	 usefulness	 of	 DUS	 in	 AMI	 in	 acute	setting.		Therefore	we	set	out	 this	 research	project	about	early	 identification	of	AMI	 in	 the	Emergency	 Department	 based	 on	 a	 stepwise	 approach	 aiming	 for	 the	 following	endpoints:	
• PRIMARY	END	POINT:	To	create	a	new	clinical	diagnostic	tool	(CDT)	for	the	evaluation	 of	 pre-test	 probability	 of	 acute	mesenteric	 ischemia	 in	 patients	with	 acute	 abdominal	 pain	 of	 unknown	 origin.	 Furthermore	we	wanted	 to	validate	the	Wang	et	al.	novel	scoring	system	for	AMI.	
• SECONDARY	ENDPOINTS:	
o To	verify	our	new	created	CDR	in	a	prospective	population	presenting	to	the	Emergency	Department	with	suspected	AMI	
o To	assess	DUS	feasibility	and	diagnostic	accuracy	to	support	pre-test	probability	for	AMI			
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The	 research	 project	 consisted	 of	 two	 different	 consequential	 parts:	 the	 first	was	retrospective	 for	 the	primary	end	point,	 the	second	prospective	 for	 the	secondary	end-points.	Each	part	will	be	discussed	separately.	
THE	RETROSPECTIVE	STUDY	
Material	and	Methods	We	retrospectively	 searched	 the	notes	of	 all	 patients	presented	 to	 the	Emergency	Department	 of	 Policlinico	 San	 Martino	 University	 Hospital,	 Genoa,	 Italy	 and	investigated	for	acute	abdominal	pain	of	unknown	origin	between	January	2014	and	December	2015.		We	used	ICD-9	World	Health	Organization	disease	classification	to	identify	patients	diagnosed	 with	 AMI	 at	 hospital	 discharge.	 Then	 we	 matched	 electronic	 records	related	 to	 wards	 permanence	 and	 definitive	 diagnosis	 with	 the	 respective	Emergency	Department	notes.		Inclusion	criteria	were	as	follow:	
• Admission	 for	abdominal	pain	without	an	obvious	diagnosis	of	origin	after	first	clinical	evaluation	in	the	ED;	
• They	 should	 have	 undergone	 abdomen	 CT	 angiography,	 mesenteric	angiography,	 emergency	 laparotomy	 or	 abdomen	 ultrasound	 with	 the	specific	request	to	investigate	for	AMI.		Exclusion	criteria	were	as	follow:	
• Age<18	years	
• Recent	abdominal	trauma	
• Cancer	history	
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• Pregnancy		In	order	to	consider	all	possible	variables	related	to	AMI,	we	collected	information	from	medical	notes	about	age,	gender,	medical	history,	presence	of	cardiovascular	risk	factors,	comorbidities,	vital	parameter,	laboratory	test,	radiological	imaging	test	done	in	the	ED,	and	the	adopted	treatment.		All	patients	underwent	abdomen	CTA,	DUS	 for	porto-mesenteric	 thrombosis,	open	laparotomy,	 or	 angiography.	 AMI	 cases	 were	 then	 divided	 into	 OMI	 (signs	 of	emoboli	or	critical	stenosis	>70%	of	the	arterial	mesenteric	vessels),	NOMI	(patency	of	 the	 main	 arterial	 and	 venous	 mesenteric	 branches	 with	 signs	 of	 	 reduced	 or	absent	 bowel	wall	 enhancement,	 bowel	wall	 thickening,	mesenteric	 fat	 stranding,	pneumatosis	 suggestive	 of	 ischemic	 insult)	 and	 MVT	 (presence	 of	 complete	 or	partial	 mesenteric	 veins	 and/or	 portal	 vein	 thrombosis	 with	 or	 without	 signs	 of	bowel	ischemic	insult).	AMI	 diagnosis	 within	 the	 ED	 presentation,	 3-month	 mortality,	 adverse	 outcome	(bowel	perforation,	septic	or	haemorrhagic	shock,	intensive	therapy	unit	admission,	cardiac	arrest),	and	length	of	hospital	staying	were	recorded.	We	calculated	for	each	patient	the	novel	scoring	model	suggested	by	Wang	et	al.	80	giving	 a	 0.5	 point	 for	 white	 cell	 count	 (WCC)	 ≤19.6x10/L,	 1	 point	 for	WCC>19.6x10/L,	 1	 point	 for	 RDW	 ≤15%,	 2	 points	 for	 RDW>15%,	 0.5	 point	 for	MPV≤9.3fL,	1	point	for	MPV>9.3fL,	1	point	for	D-dimer≤693ng/mL	and	2	points	for	D-dimer>693mg/mL.	Its	diagnostic	accuracy	was	investigated	with	ROC	analysis.				On	the	basis	of	the	multivariate	regression	analysis,	we	derived	an	our	own	scoring	model	 system	using	 all	 factors	 significantly	 associated	with	AMI,	 trying	 to	 further	
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adapt	it	for	OMI,	NOMI	or	MVT	condition	as	clinical	presentation	and	management	are	different.	Furthermore	 we	 applied	 the	 derived	 model	 to	 our	 study	 population	 in	 order	 to	verify	its	diagnostic	accuracy.	Statistical	analysis	Results	were	 shown	as	median	and	 interquartile	 range	or	percentage.	Continuous	variables	were	compared	with	t-test	or	Mann-Whitney	test	when	appropriated	(for	parametric	and	non-parametric	respectively).	Categorical	variables	were	compared	with	Pearson	chi-square	test.	Those	variables	found	to	be	strongly	associated	with	the	outcome	measure	(P<0	 .05)	were	combined	using	either	recursive	partitioning	or	logistic	regression.	The	objective	was	to	find	the	best	combinations	of	predictor	variables,	 ie,	 those	 highly	 sensitive	 for	 detecting	 the	 outcome	 measure	 while	achieving	 the	 maximum	 possible	 specificity.	 Building	 of	 the	 regression	 model	proceeded	with	 forward	 stepwise	 selection	 until	 no	 variables	met	 the	 criteria	 for	entry	 (P	 <0.05)	 or	 removal	 (P	 >0.10)	 for	 the	 significance	 levels	 of	 the	 likelihood-ratio	test.	The	crude	and	multivariate	adjusted	odds	ratio	(OR)	with	95%	confidence	interval	(CI)	was	estimated.	The	derived	CDT	was	cross-validated	by	comparing	the	classification	of	all	patients	to	their	actual	status	for	the	primary	outcomes	allowing	estimates,	with	95%	CIs,	the	sensitivity	and	specificity	of	the	score.	Then,	according	to	Lee	et	al.,	we	assigned	for	β-coefficient	<0.6,	0.7	to	1.3,	1.4	to	2.0,	and	>2.1	a	value	of	 1,	 2,	 3,	 and	 4	 respectively.88	Finally	 the	 receiver	 operating	 characteristic	 (ROC)	curve	 was	 used	 to	 assess	 diagnostic	 accuracy	 of	 the	 created	 rule	 on	 the	 given	population.	 Statistical	 analysis	was	performed	using	 the	SPSS	 software	version	21	(IBM	Corp.	©	Copyright	IBM	Corporation	et	al.	Chicago	USA).		
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Results	Between	January	2014	and	December	2015,	275	were	found	being	investigated	for	AMI.	 Of	 those	 56	 were	 not	 eligible	 because	 hospital	 access	 was	 not	 through	Emergency	Department,	 they	mainly	 underwent	major	 cardio-vascular	 surgery	 or	had	 long	 length	 of	 stay	 in	 ICU.	 Of	 the	 219	 eligible	 patients,	 76	 had	 missing	 or	incomplete	medical	record	so	that	was	impossible	to	gather	all	predictive	variables	leaving	143	patients	for	full	analysis.		
	
	
Figure	4.	Selection	of	patients	for	the	study	
Pt	who	were	investigated	for	AMI	n=275	
219	eligible	patients	
143	pt	available	for	full	analysis	
Pt	having	missing	or	incomplete	records	n=76	
Pt	not	assessed	in	the	ED	n=56	
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At	hospital	discharge,	90	patients	had	a	confirmed	diagnosis	of	AMI,	whilst	of	the	53	non-AMI	patients	other	diagnosis	were:	diverticulitis	(n=17),	bowel	adhesion	(n=9),	aortic	 abdominal	 aneurism	 (n=3),	 acute	 pancreatitis	 (n=5),	 incarcerated	 hernia	(n=4),	 volvulus	 (n=5),	 acute	 cholangitis	 (n=3),	 pneumonia	 (n=3),	 no	 specific	diagnosis	 (n=5).	 Of	 the	 90/143	 patients	 with	 AMI,	 n=15(16%)	were	 classified	 as	OMI,	n=29(32%)	as	NOMI,	n=46(51%)	as	MVT.				Table	1	shows	the	characteristics	of	 the	 non-AMI	 and	 AMI	 population,	 AMI	 population	 is	 further	 divided	 into	 OMI,	NOMI	and	MVT.																		
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TABLES	1.	Characteristics	of	patients	investigated	for	AMI	
	 Non-AMI	
(n=53)	
AMI(n=90)	 OMI	(n=15)	 NOMI(n=29)	 MVT(n=46)	
Age	 73,75±14,5	 71,56±14,6	 74,27±12,9	 81,38±12,7	 65,48±13	
Female	 27(18,9%)	 47(32,9%)	 9(6,3%)	 19(13,3%)	 19(13,3%)	
Risk	Factors	
Smoke	 6(4,6%)	 14(9,8%)	 1(0,7%)	 3(2,1%)	 10(7%)	
High	cholesterol	 13(9,1%)	 24(16,8%)	 9(6,3%)	 9(6,3%)	 6(4,2%)	
High	blood	pressure	 26(18,2)	 52(36,4%)	 11(7,7%)	 21(14,1%)	 20(14%)	
Diabetes	 6(4,2%)	 13(9,1%)	 4(2,8%)	 5(3,5%)	 4(2,8%)	
Family	history	 4(2,8)	 5(5,3%)	 3(2,1)	 1(0,7%)	 1(0,7%)	
Comorbidity	
CAD	 12(8,4%)	 16(11,2%)	 5(3,5%)	 10(7%)	 1(0,7%)	
Cerebral	vasculopaty	 1(0,7%)	 15(10,6%)	 3(2,1%)	 10(7%)	 2(1,4%)	
Carotid	atherosclerosis	 0(0%)	 5(3,5%)	 0	 2(1,4%)	 3(2,1%)	
Peripheral	artery	
disease	
3,(2,1%)	 9(6,3%)	 3(2,1%)	 5(3,5%)	 1(0,7%)	
Atrial	fibrillation	 4(2,8%)	 15(10,5%)	 4(2,8%)	 8(5,6%)	 3,(2,1%)	
AAA	 1(0,7%)	 4(2,8%)	 1(0,7%)	 2(1,4%)	 1(0,7%)	
Chronic	liver	disease	 7(4,9%)	 32(22,4%)	 1(0,7%)	 0	 31(21,7%)	
Medications	
Digoxin	 1(0,7%)	 4(2,8%	 0	 4(2,8%)	 0	
b-blocker	 14(9,8%)	 30(21%)	 11(7,7%)	 13(9,1%)	 6(4,2%)	
Ca-antagonist	 7(4,9%)	 8(5,6%)	 3(2,1%)	 4(2,8%)	 1(0,7%)	
Signs	and	symptoms	
Acute	abdominal	
pain(<24h)	
34(23,8%)	 55(38,5%)	 9(6,3%)	 17(11,9%)	 29(20,3%)	
Abdominal	pain	>48h	 2(1,4%)	 10(7%)	 1(0,7%)	 2(1,4%)	 7(4,9%)	
others	 17(11,9%)	 14(9,8%)	 	 	 	
Vitals	Parameter	
SBP	 132,31±28,3	 133,8±30	 140,71±35,4	 139,44±32,3	 126,58±24,8	
DBP	 77,04±13,3	 77,3±15,7	 79,43±19,1	 78,7±18,1	 74,8±12,1	
Temperature	 37,2±0,7	 36,9±0,6	 37±0,3	 36,6±0,7	 37,1±0,4	
Heart	rate	 81,6±15,2	 99,1±25,3	 97,4±31,2	 98,3±22,5	 89,7±15,3	
Laboratory	
Leucocytes	 9,94±2,6	 11,3±4,9	 10,07±3,4	 14,5±3,1	 9,6±5,6	
Neutrophyl	 71,6±16,4	 78,4±12,9	 77±12,5	 78,8±9,7	 68,1±14	
D-dimer	 334,5±77,07	 405±87	 430±14,5	 382,7±105,1	 490±98	
Hospital	LOS	 20,06±31,2	 17,7±32	 15,57±18,7	 14,3±20,2	 20,23±41	
Adverse	outcome	 12(8,5%)	 19(13,4%)	 4(2,8%)	 11(7,7%)	 4(2,8%)	
Death	 14(9,9%)	 24(16,9%)	 7(4,9%)	 14(9,9%)	 3(2,1%)	
	 	 	 	 	 	AMI:	 Acute	 Mesenteric	 Ischemia,	 OMI:	 Occlusive	 Mesenteric	 Ischemia,	 NOMI:	 Non	 Occlusive	Mesenteric	 Ischemia,	 MVT:	 Mesenteric	 Venous	 Thrombosis,	 CAD:	 Coronary	 Artery	 Disease,	 AAA:	Abdominal	aortic	aneurysm,	SBP:	Systolic	Blood	Pressure,	DBP:	Diastolic	blood	pressure,				Overall	AMI	mortality	was	16,9%,	 almost	doubled	with	 respect	 to	non-AMI	 group	(9,9%).	However,	in	the	OMI	and	NOMI	subgroup,	mortality	reached	almost	50%	as	7/15	 OMI	 and	 14/	 NOMI	 patients	 died.	 In	 the	MVT	 subgroup	 only	 3/46	 patients	died.	Length	of	hospital	stay	was	11,5%	shorter	in	AMI	population	than	in	non-AMI.	
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Wang’s	 score	 was	 impossible	 to	 calculated	 in	 76	 patients	 because	 our	 central	laboratory	stopped	to	report	the	MPV	value	for	the	emergency	department	so	that	it	was	applied	just	in	77	cases.	ROC	analysis	for	Wang’s	score	diagnostic	accuracy	for	AMI	showed	an	AUC	of	0,618	(95%	CI	0.45-0.77)	with	a	sensitivity	and	specificity	for	the	indicated	4	point	result	of	76,7%	and	51,2%	respectively.		As	 we	 found	 that	 OMI	 and	 NOMI	 populations	 were	 similar	 in	 terms	 of	 age,	 risk		factors,	 comorbidities,	 medications	 predisposing	 AMI	 we	 considered	 these	population	group	together	for	multivariate	analysis.				In	 Table	 2	 we	 reported	 multivariate	 regression	 analysis	 results	 of	 the	 variables	significantly	related	to	AMI	(p<0.05),	they	were:		
• the	presence	of	one	risk	factor	
• the	cumulative	amount	of	comorbidity	
• abdominal	pain	“out	of	proportion	to	clinical	signs”	
• Systolic	blood	pressure	
• Heart	rate	
• Neutrophils	percentage		Furthermore	we	found	that	some	variables	were	related	to	OMI	and	NOMI	patients	but	not	to	MVT.	Factors	significantly	associated	only	with	OMI	and	NOMI	were:	
• Age>65	
• Digoxin,	beta-blocker	or	Ca-antagonist	assumption	Factors	significantly	associated	only	with	MVT	were:	
• History	of	chronic	liver	disease	
• Abdominal	pain	>48h	
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Table	2.	Factors	significantly	associated	with	AMI	at	multivariate	logistic	regression	
	 B	 S.E.	 Wald	 Exp(B)	 95%	CI	per	EXP(B)	
	 	 	 	 	 min	 max	
One	RISK	FACTOR	 0,055	 0,24	 0,052	 1,056	 0,661	 1,689	
Cumulative	COMORBODITY	 1,191	 0,403	 8,727	 3,29	 1,493	 7,251	
ABdominal	pain	“out	of	
proportion”	to	clinical	signs	
with	onset	<24h	
1,27	 1,31	 0,939	 3,581	 0,271	 47,239	
SBP	 0,001	 0,008	 0,006	 1,001	 0,985	 1,017	
HR	 -0,002	 0,015	 0,022	 0,998	 0,969	 1,027	
Neutrophils_Perc	 0,019	 0,021	 0,856	 1,019	 0,979	 1,062		
• Factors	significantly	associated	only	with	OMIorNOMI	at	multivariate	logistic	regression	
	 B	 S.E.	 Wald	 Exp(B)	 95%	CI	per	EXP(B)	
	 	 	 	 	 min	 max	
Age65	 1,118	 0,603	 3,439	 3,059	 0,938	 9,969	
Medications	(digoxin	or	
beta-blocker-or	Ca-
antagonist	
0,36	 0,465	 0,622	 1,30	 0,58	 3,59	
	
• Factors	significantly	associated	only	with	MVT	at	multivariate	logistic	regression	
	 B	 S.E.	 Wald	 Exp(B)	 95%	CI	per	EXP(B)	
	 	 	 	 	 min	 max	
COMORBODITY_Chronic	
liver	disease	 2,196	 1,223	 3,225	 8,991	 0,818	 98,818	
ABdominal	pain	>48h	 0,99	 1,45	 0,948	 1,19	 0,57	 5,98			The	derived	scoring	model,	so	called	AMI-score	(see	Table	3),	allowed	to	assign	from	1	to	4	points	for	each	specified	item.	As	some	variables	were	related	to	OMI	and	NOMI	but	not	to	MVT	and	vice	versa,	we	build	up	the	scoring	model	with	six	common	items	and	then	two	specific	items	for	OMI	 and	 NOMI	 together	 plus	 two	 specific	 items	 for	 MVT.	 These	 information	 are	quickly	 achievable	 in	 the	 ED	 and	 based	 on	 patient	 general	 and	 clinical	characteristics,	blood	test	and	vital	parameters.		
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Table	3.	The	derived	scoring	model	for	AMI	(the	so-called	AMI-score)		
	 AMI	 To	be	
ADDED	
querying	
OMI	or	
NOMI	
To	be	added		
querying	
MVT	
One	CV	risk	factor	 2	point	 	 	
Cumulative	comorbidity		 1	point	each	 	 	
Abdominal	pain	out	of	proportion	to	clinical	
signs	
4	points	 	 	
Altered	systolic	blood	pressure	(<90	or	
>140)	
1	point	 	 	
Altered	heart	rate	(<60	or>100	bpm)	 1	point	 	 	
Neutrophils	percentage>75	 1	point	 	 	
Age	>65yo	 	 4	points	 	
Assumption	of	one	of	the	following	
medication(Digoxin,	beta-blocker	or	Ca-
antagonist)	
	 2	points	 	
Chronic	liver	disease	 	 	 4	points	
Abdominal	pain	onset	>48h	 	 	 3	points	
CV	risk	factors:	smoke,	hypercholesterolemia,	arterial	hypertensione,	diabetes	mellitus,	family	history	for	cardiovascular	disease	
Comorbidity	considered:	coronary	artery	disease,	cerebral	vasculopathy,	carotid	atherosclerosis,	peripheral	arterial	occlusive	disease,	aortic	aneurism,	atrial	fibrillation,					Afterward	we	applied	each	derived	score	to	assess	the	pre-test	probability	of	OMI-NOMI	and	MVT.	For	OMI-NOMI	the	ROC	analysis	showed	an	AUC	of	0,733	(CI	95%:	0,62-0,82)	obtaining	for	the	best	cut-off	score	>4	91.2%	and	47.5%	of	sensitivity	and	specificity	 respectively.	 For	 MVT,	 with	 a	 best	 cut-off	 score>4	 AUC	 was	 0,772	 (CI	95%:	0,686-0,859)	with	88%	and	56%	of	sensitivity	and	specificity	respectively.			
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Figure	 5.	 ROC	 curve	 of	 AMI-score	for	OMI-NOMI	
	
	
	
	
	
	
	
	
	
Figure	6.	ROC	curve	of	AMI	score	for	MVT	
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Discussion	We	 conducted	 this	 retrospective	 observational	 study	 to	 identify	 a	 new	 scoring	model	 to	 support	AMI	diagnosis	 in	 the	 emergency	department.	 From	multivariate	regression	analysis	we	identified	six	common	items	for	AMI	and	two	more	specific	items	 for	 OMI/NOMI	 and	 MVT	 respectively.	 We	 found	 an	 acceptable	 overall	diagnostic	accuracy	(AUC=0.73	for	OMI-NOMI	and	AUC=0.77	for	MVT	respectively)	with	high	level	of	sensitivity	that	may	allow	to	include	all	patient	with	possible	AMI	even	if	this	mean	to	have	a	positive	score	in	patients	without	AMI.		As	AMI	presentation	characteristics	are	insidious,	the	score	has	to	represent	many	aspects	of	the	disease.	Patients	with	at	least	one	cardiovascular	risk	factors	showed	an	odds	ratio	of	1,056(CI	95%	0.661-1.68,	2	points	assigned	by	 the	presence	of	at	least	 one	 risk	 factor).	 The	presence	 of	 cardiovascular	 comorbidities	 seemed	 to	 be	strongly	 related	 to	AMI	 (odds	 ratio	of	3.58;	95%	CI1.49-7.25,	1	point	assigned	 for	each	comorbidity)	 reflecting	 the	 fact	 that	atherosclerosis	 in	an	ubiquitous	disease.	
89The	item	“abdominal	pain	out	of	proportion	to	clinical	signs”	showed	the	strongest	correlation	with	AMI	 (odds	ratio	3,58	with	95%	CI	0,27-47,23,	4	points	assigned).	Although	it	can	be	argued	that	this	is	a	subjective	judgement	and	the	95%	CI	is	wide,	whether	used	by	experienced	physicians	may	make	the	difference.	Altered	SBP,	HR	and	 increased	 neutrophil	 percentage	 showed	 a	 mild	 correlation	 with	 AMI,	 but	allowed	the	score	to	be	more	sensible	for	systemic	alterations.	About	the	scoring	system	suggested	by	Wang,	we	were	able	to	calculated	it	in	only	50%	 of	 our	 population	 because	 of	 MPV	 lacking	 values.	 This	 may	 have	 cause	calculation	bias,	however	we	found	a	lower	diagnostic	accuracy	than	that	reported	in	 their	 work	 (sensitivity	 97.8%	 and	 specificity	 91.8%	 for	 criterion>4).	
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Furthermore,	as	MPV	is	not	everywhere	a	routine	test	and	for	example	our	central	laboratory	stopped	to	evaluate	 it,	 the	score	suggested	by	Wang	et	al.	doesn’t	seem	widely	applicable	other	than	reliable.		In	 our	 population	 we	 found	 a	 lower	 percentage	 of	 OMI	 and	 higher	 of	 MVT	 than	reported	in	literature	5,90	,	however	this	could	be	partially	explained	by	the	fact	that	the	 surrounding	 area	 of	 Genoa	 has	 an	 high	 epidemiological	 distribution	 of	 liver	chronic	liver	disorders.	91	Looking	 at	 the	 general	 characteristics	 of	 AMI	 sub-population,	we	 found	 that	MVT	seems	 to	have	different	 feature	 from	OMI	and	NOMI:	 the	population	was	younger	(median	 age	 of	 65,48	 vs	 77,8),	male	 gender	was	 prevalent	 (27/46	 vs	 16/44)	 and	they	had	a	better	outcome	in	terms	of	mortality	and	adverse	outcome	(see	Table	1)		in	line	with	Harnik	et	al.	findings.92		Therefore	 constructing	a	 specific	pre-test	 score	 for	OMI-NOMI	and	a	different	one	for	MVT	reflects	their	different	characteristics	in	terms	of	clinical	presentation	and		LIMITATIONS	One	of	the	limitation	of	this	study	is	a	possible	selection	bias,	we	had	to	find	patients	from	a	ICD-9	based	system	with	specific	key	words.	 In	case	of	 incorrect	use	of	 the	specific	code	for	AMI,	many	patients	may	have	been	overlooked.	Furthermore	as	we	had	 to	 retrospectively	 look	at	 the	medical	notes,	many	required	 information	were	partially	 or	 not	 at	 all	 present,	 therefore	we	had	 to	 remove	 from	 analysis	 even	 76	patients.	 Connected	 to	 this,	 the	 sample	 size	was	 heavily	 outnumbered	 so	 that	 the	power	of	 the	study	was	reduced.	Nonetheless,	 considering	AMI	a	 rare	disease,	 the	sample	population	given	was	enough	to	obtain	significant	results.		
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Conclusions	Even	 if	 not	 conclusive	 and	 done	 on	 a	 relative	 small	 sample,	 this	 study	 may	contribute	to	clinical	decision	making	in	assessing	patients	with	abdominal	pain	of	unknown	origin	in	whom	AMI	has	to	be	considered.	As	abdomen	CT	angiography	is	the	best	imaging	of	choice	to	diagnose	AMI,	our	AMI-score	can	support	the	decision	to	request	it	earlier	during	patient	workup.	The	next	step	of	our	research	project	is	a	prospective	validation	study	of	this	score	with	the	support	of	the	abdomen	DUS.																	
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THE	PROSPECTIVE	STUDY	
Liaison	With	The	Retrospective	Study	From	the	above	mentioned	retrospective	observational	study,	we	identified,	on	the	basis	of	a	multivariate	analysis,	a	diagnostic	score	to	diagnose	AMI	among	patients	presenting	to	the	Emergency	Department	with	abdominal	pain	of	unknown	origin.	The	 aim	of	 that	 study	was	 to	 create	 a	practical	 clinical	 diagnostic	 tool	 in	 order	 to	guide	physicians	toward	an	early	AMI	diagnosis.		Successively	we	 projected	 a	 prospective	 study	with	 the	main	 aim	 to	 validate	 this	CDT	 in	 a	 real-life	 population	 presenting	 to	 the	 Emergency	 Department	 with	abdominal	of	unknown	origin.	Furthermore	we	decided,	as	second	aim	of	the	study,	to	 boost	 it	 with	 abdomen	 duplex	 ultrasound	 (DUS)	 to	 assess	 whether	 this	 early	exam	may	support	the	diagnosis	of	AMI.	
Material	and	Methods	This	 prospective	 pilot	 validation	 study	 was	 carried	 out	 at	 the	 Emergency	Department	 of	 the	 Policlinico	 San	 Martino	 University	 Hospital	 of	 Genoa,	 Italy,	between	October	2016	and	December	2017.		
Patients	were	eligible	for	the	study	if	they	fulfilled	all	the	following	criteria:		
• age	>18	years	old;		
• complaining	 symptoms	 of	 acute	 abdominal	 and/or	 altered	 bowel	 habit	and/or	hematochezia	at	ED	presentation;		
• the	 clinical	 need,	 after	 initial	 workup,	 to	 request	 an	 abdomen	 computed	tomography,	 possibly	 with	 contrast	 medium	 for	 angiography,	 to	 obtain	 a	diagnosis;		
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• evidence	of	porto-mesenteric	thrombosis	to	abdomen	ultrasound	
• capacity	to	sign	a	written	informed	consent	Exclusion	criteria	were	any	of	the	following:	
• a	 clear	 diagnosis	 after	 initial	 medical	 assessment	 such	 as:	 gallstones,	cholecistitis,	pancreatitis,	acute	hepatitis,	appendicitis,	renal	or	biliary	colic;	
• known	 or	 found	 pregnancy	 and/or	 pain	 related	 to	 gynaecological	 known	problem	
• history	of	trauma	within	a	month	from	ED	presentation	
• 	suspected	alimentary	intoxication	Data	 collection	 was	 carried	 out	 prospectively	 and	 recorded	 in	 real	 time	 on	 a	standardized	clinical	research	form	(CRF).	All	the	following	data	were	reported:	age,	gender,	 cardiovascular	 risk	 factors,	 history	 of	 cardiovascular	 disease	 and	 liver	cirrhosis,	 	vital	parameters	at	ED	admission,	clinical	feature	of	the	abdominal	pain,	laboratory	 test	 (leucocytes,	neutrophils,	CPK,	LDH,	D-dimer,	venous	 lactate,	C-RP).	Length	 of	 hospital	 staying	 was	 recorded.	 Furthermore	 we	 reported:	 adverse	outcome	 during	 hospital	 staying	 described	 as	 bowel	 perforation,	 hemorrhagic	shock,	 septic	 shock,	 cardiac	 arrest	 and	 intensive	 care	 unit	 admission;	 treatment	(surgical,	 endovascular	 and/or	 medical	 therapy);	 in-hospital	 and	 3-months	mortality.	Then	for	each	patient	we	calculated	the	new	suggested	AMI-score	and	we	assessed	its	 diagnostic	 accuracy	 for	 AMI	 according	 to	 CTA	 findings.	 At	 the	 previous	retrospective	study,	an	AMI-score	result	>4	in	case	of	suspected	OMI-NOMI	showed	91.2%	and	47.5%	of	sensitivity	and	specificity	respectively	whilst	for	MVT	a	result	>4	had	88%	and	56%	of	sensitivity	and	specificity	respectively.	
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MDCT	and	CT	angiography	diagnostic	criteria		
An	abdomen	MDCT	was	performed	 in	all	patients	 in	 the	ED	as	dictated	by	clinical	judgment.	The	report	was	used	as	outcome	measure	to	distinguish	between	patients	with	and	without	acute	mesenteric	ischemia	(AMI).	The	timings	and	decision	for	MDCT	were	independent	of	the	study.	A	plain	CT	was	enhanced	 with	 iodinated	 contrast	 medium	 for	 angiography	 (including	 arterial,	venous,	and	portal	phase)	unless	contraindicated.	Contrast	medium	was	not	infused	if	 there	was	 renal	 impairment	 (defined	 as	 creatinine	 >	 1.5	mg/dl/	 >	 150	 μmol/l)	and/or	 known	 allergy	 to	 iodine-based	 contrast	media.	 OMI	was	 diagnosed	 by	 the	presence	 of	 emboli	 or	 thrombi	 visualized	 as	 filling	 defects	 or	 critical	 stenosis	respectively	 in	 the	 lumen	 of	 celiac	 axis,	 superior,	 or	 inferior	 mesenteric	 artery.	NOMI	was	diagnosed	by	the	finding	of	patent	main	arterial	and	venous	vessels	with	a	reduction	in	enhancement	and	thickening	of	the	bowel	wall.	MVT	was	diagnosed	by	 the	 presence	 of	 intraluminal	 filling	 defect	 and	 engorgement	 of	 the	mesenteric	veins	or	the	main	portal	vein	with	or	without	signs	of	bowel	wall	involvement.	
Duplex	ultrasound	evaluation		
All	 DUS	 examinations	 were	 performed	 as	 soon	 as	 possible	 and	 always	 within	 6	hours	from	hospital	presentation.	Time-to-DUS	assessment	and	DUS	exam	duration	were	 recorded	 in	 minutes.	 Quality	 of	 images	 were	 classified	 into	 four	 classes:	optimal,	good,	mediocre,	and	not	diagnostic.	Every	time	a	patient	was	eligible	for	the	study,	 the	 ED	 staff	 contacted	 the	 sonographer,	 an	 emergency	 physician	 who	performed	 all	 DUS	 exams.	 He	 was	 trained	 in	 basic	 ultrasound	 (point-of-	 care	thoracic	ultrasound,	echocardiography,	and	abdominal	ultrasound)	with	additional	
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training	in	vascular	Doppler	ultrasound.	This	was	supplemented	by	further	training	from	 a	 one-day	 dedicated	 course	 on	 mesenteric	 vessel	 ultrasound	 and	 a	 daily	experience	of	abdominal	DUS.		
The	sonographer	was	blinded	to	abdominal	CTA	reports.	DUS	was	performed	using	a	 Mindray	 M7	 Premium	 ultrasound	 machine	 using	 standard	 abdominal	 software	and	 a	 curvilinear	 phased	 array	 transducer	 (4.5–6MHz).	 Duplex	 assessment	consisted	 of	 the	 evaluation	 of	 the	 superior	 mesenteric	 artery	 with	 a	 beam	 angle	between	40°	 and	60°	 and	 a	 1.5	mm	gate.	93	SMA	 is	 the	 best	 accessible	mesenteric	vessel	 to	 DUS	 and	 we	 deemed	 that	 CA	 and	 IMA	 would	 have	 been	 difficult	 and	unreliable	 to	 measure. 94 	Moreover	 some	 theories	 affirm	 that,	 as	 mesenteric	circulation	 is	 interconnected	and	an	auto-regulation	 system	 is	promptly	activated,	even	a	single	vessel	altered	flow	may	underline	an	ischemic	insult	to	gut.	95,96	
SMA	was	evaluated	in	sagittal	plane	with	the	duplex	gate	placed	within	2	cm	of	the	aorta.	We	considered	normal	peak	systolic	velocity	(PSV)	values	to	be	80–200	cm/s	for	the	SMA.	97Thus,	PSV	abnormal	velocities	were	considered	less	than	90	cm/s	or	greater	 than	 190	 cm/s	 for	 CA	 and	 less	 than	 80cm/s	 or	 greater	 than	 200cm/s	 for	SMA.	 71High	 velocities	 are	 an	 indication	 of	 stenosis	 greater	 than	 30%,	whereas	 a	reduced	or	absent	flow	speed	represents	subtotal	occlusion/occlusion	pattern	or	is	expression	of	low	cardiac	output	or	shock	state.	72	We	further	recorded	end	diastolic	velocity	 (EDV)	 (20-40cm/sec	 values	were	 considered	 normal)	 and	 resistive	 index	(RI)	(normal	value	≥70).	68,71	
Mesenteric	 and	 portal	 veins	 were	 evaluated	 both	 with	 color	 and	 duplex	 mode	recording	 vessels	 patency,	 quality	 of	 the	 blood	 flow,	 bowel	 wall	 features.	 MVT,	
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partial	or	complete,	was	define	as	filling	defect	of	mesenteric	or	portal	veins	lumen	with	absence	of	color	image	and	no	detectable	duplex	signal.		
Bowel	 wall	 thickness	 was	 sampled	 for	 small	 intestine	 at	 the	 level	 of	 right	 lower	quadrant	close	to	the	umbilicus	or	where	ultrasound	showed	obvious	abnormality	such	 as:	 increased	 wall	 thickness	 >4mm,	 reduced	 power	 color	 enhancement,	decreased	 peristalsis,	 intramural	 or	 intraperitoneal	 gas,	 and	 peritoneal	 fluid.	 For	colon	wall	 thickness	 was	 sampled	 at	 the	 level	 of	 left	 flank	 (descending	 colon)	 or	where	ultrasound	showed	the	same	abnormalities	described	for	small	intestine.74,75	
Entry	to	the	study	did	not	delay	any	participants	from	undergoing	diagnostic	MDCT	imaging	because	of	DUS	evaluation.	
Ethical	review		
The	 study	 was	 carried	 out	 in	 accordance	 with	 the	 Declaration	 of	 Helsinki	 and	approved	 by	 our	 local	 ethical	 committee.	Written	 informed	 consent	was	 obtained	from	 all	 patients.	 The	 study	was	 registered	 by	 the	 Regional	 Ethical	 Committee	 of	Liguria	(reference	number:	056REG2106).		
Statistical	analysis		
We	 describe	 study	 participants	 using	 means,	 ranges	 and	 standard	 deviations	 for	continuous	variables,	and	frequencies	with	proportions	for	categorical	variables.	To	assess	the	differences	between	patients	with	and	without	AMI,	the	Student	t-test	or	the	 Fisher	 exact	 test	was	 used	 to	 compare	 quantitative	Gaussian	 or	 non-Gaussian	variables,	respectively.	The	Kolmogorov–Smirnov	statistical	test	was	used	to	verify	
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the	normality	of	data	distribution.	Receiver	operating	characteristic	(ROC)	analysis	was	used	to	assess	the	diagnostic	accuracy	of	AMI-score>4	for	OMI-NOMI	and	>4	for	MVT.	 DUS	 variables	 between	 AMI	 and	 non-AMI	 population	 were	 analyzed	 and	altered	values	were	compared	using	the	χ2.	Furthermore	sensitivity	(SE),	specificity	(SP),	 positive	 and	 negative	 predictive	 value	 (PPV	 and	 NPV,	 respectively),	 and	likelihood	ratios	of	PSV,	EDV	and	RI	were	calculated	against	the	reference	standard	of	 CTA	 positive	 for	 AMI.	 The	Hosmer–Lemeshow	 goodness-of-fit	 test	was	 used	 to	evaluate	model	calibration.		The	 SPSS	 software	 v.21	 (IBM	 Software,	 Amonk,	 New	 York,	 USA),	 held	 by	 the	University	of	Siena	Inc.,	and	Matlab	v.5	(The	MathWorks,	Inc.,	Natick,	USA)	package	were	used	for	statistical	computations	and	score	model	design,	respectively.		
Results	Over	 a	 14-months	 period,	 45	 patients	 were	 screened	 for	 the	 study	 but	 six	 were	excluded	 as	 per	 exclusion	 criteria	 and	 two	 didn’t	 give	 their	 consent	 leaving	 37	patients	for	full	analysis.	Follow-up	about	hospital	adverse	outcome,	treatment	and	death	 within	 three	 months	 enrolment	 was	 achieved	 for	 all	 37	 patients.	 8/37	patients	didn’t	received	contrast	media	at	MDCT	because	of	renal	failure	(six	cases)	and	severe	anaphylaxis	reaction	(two	cases).	AMI	was	diagnosed	 in	eight	patients	(21,6%),	of	 this	 two	were	OMI,	six	NOMI	and	two	MVT.	OMI	cases	had	both	SMA	involvement,	one	case	for	emboli	occlusion	in	a	new	onset	AF	and	the	other	was	due	to	critical	stenosis	from	atherosclerosis	plaque.	Of	 the	 six	 NOMI	 cases,	 three	 had	 distal	 ileum,	 cecum	 and	 ascending	 colon	involvement,	one	the	transverse	colon	and	two	descending	colon	and	sigma.	About	
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MVT	 cases	 just	 one	 of	 the	 two	 had	 signs	 of	 bowel	 ischemia,	 the	 other	 one	 just	superior	mesenteric	vein	and	portal	vein	thrombosis,	both	of	them	had	cirrhosis.			All	other	diagnosis	are	reported	in	figure	7.		
	
Figure	7	Final	diagnosis	after	ED	workup	
	Patients	characteristics	of	AMI	and	non-AMI	population	are	reported	in	Table	4.	Length	of	hospital	stay	was	8±12,6	SD	and	29±13,31SD	for	AMI	and	non-AMI	group	respectively.					
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OVERALL	DIAGNOSIS	AFTER	Abdomen	CTA	
AMI	
Diverticolosis	
Cancer	
IBD	or	infectious	gastroenteritis	
Incarcerated	hernia	
Adherence	
Volvulus	
Spleen	hematoma	
Appendicitis	
Pneumonia	
Iliac	artery	occlusion	
Cholecistitis	
Constipation	
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TABLES	4.	Characteristics	of	patients	investigated	for	AMI		
	 Non-AMI	
n=29	
AMI	n=8	 P	value	
Age	 74±13,94	 79,86±15,47	 0.33	
Female	 12	(32,4%)	 5(13,5%)	 0.28	
RISK	FACTORS	
Smoke	 9(24,3%)	 2(5,4%)	 0.74	
High	cholesterol	 3(8,1%)	 1(2,7%)	 0.86	
High	blood	pressure	 12(32,4%)	 4(10,8%)	 0.66	
Diabetes	 1(2,8%)	 1(2,8%)	 0.33	
Family	history	 2(5,6%)	 0	 	
COMORBIDITIES	
CAD	 5(13,5%)	 1(2,8%)	 0.74	
Cerebral	vasculopaty	 6(16,2%)	 3(8,1%)	 0.32	
Carotid	
atherosclerosis	
1(2,8%)	 0	 0.59	
Peripheral	artery	
disease	
1(2,8%)	 0	 0.59	
Atrial	fibrillation	 2	(5,4%)	 2(5,4%)	 0.17	
AAA	 1(2,8%)	 1(2,8%)	 0.44	
Chronic	liver	disease	 0		 2	(5,4%)	 0.11	
MEDICATIONS	 10(27%)	 4(10,8%)	 0.21	
SIGNS	AND	SYMPTOMS	
Acute	abdominal	
pain(<24h)	
19(40,1%)	 5(13,5%)	 0.07	
Abdominal	pain	
>48h	
8	(21,9%)	 0	 0.13	
others	 12	(32,4%)	 1	(2,8%)	 0.17	
VITAL	PARAMETERS	
SBP	 141,9±25,4	 125,1±23,2	 0.09	
DBP	 82,4±14,9	 68,38±8,9	 0.016*	
Temperature	 	 	 	
Heart	rate	 82,5±16,8	 90,3±23,9	 0.29	
Oxigen	saturation	 96,6±2,0	 95,8±2,3	 0.43	
Body	temperature	 36,9±0,7	 37,1±1,3	 0.66	
LABORATORY	TEST	
LDH	 252±159	 261±44	 0.89	
CPK	 89±83,3	 75±15,9	 0.43	
Leukocytes	count	 13,24±6,8	 9,6±7,2	 0,24	
		Neuthrophils							
		percentage	
80,2±11,7	 75,9±13,7	 0.43	
	Lactate	 2,15±1,9	 3,65±1,9	 0.11	
	D-dimer	 2175±2237	 4937±2971	 0.12	
				C-reactive	protein	 75,3±80,7	 35,7±30,3	 0.04	
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AMI:	Acute	Mesenteric	Ischemia;	CAD:	Coronary	Artery	DIsease;	AAA:	abdominal	aortic	aneurysm,	SBP:Systolic	Blood	Pressure;	DBP:	Diastolic	Blood	Pressure;		Adverse	outcomes	were	present	in	2/8	(25%)	of	patients	with	AMI	(one	hemorragic	shock	 and	 one	 ICU	 admission)	 whereas	 in	 5/29	 (17%)	 of	 non-AMI	 group	 (three	suffered	bowel	perforation,		one	septic	shock	and	one	ICU	admission).		Two	 of	 AMI	 patients	 died	within	 hospital	 staying	 (mortality	 25%),	 and	 two	more	died	 within	 3-months	 so	 that	 cumulative	 mortality	 was	 50%.	 Among	 non-AMI	patients	two	died	within	3-months	(6,9%),	none	during	hospital	staying.		ROC	curve	of	the	AMI-score	for	OMI-NOMI	had	an	AUC	of	0.76(95%	CI:	0.52-1)	with	a	sensitivity	and	specificity	of	91%	(95%	CI:	83,3%-100%)	and	35%(95%	CI:	27%-46%)	respectively	for	a	result>4.	ROC	curve	of	the	AMI-score	for	MVT	showed	AUC	of	0.9	(95%	CI:	0.76-1.0)	with	a	sensitivity	and	specificity	of	100%	and	62%	(95%	CI	49-71%)	respectively.	See	figure	8	a-b.									
	Figure	8.	ROC	curve	of	the	AMI-score	for	OMI-NOMI	(a)	and	MVT 
a	 b	
	 44	
DUS	of	the	SMA	and	bowel	was	achievable	in	35/37	enrolled	patients	(95%)	with	an	acceptable	 overall	 quality	 of	 the	 images	 (9	were	 classified	 as	 optimal,	 19	 good,	 7	mediocre).	The	mean	execution	time	was	4,37	min	(minimum	2	minutes,	maximum	10	minutes).	About	 SMA	 evaluation,	 PSV	 had	mean	 velocity	 of	 279,17±186,1SD	 cm/sec	 in	 AMI	group	whereas	188,7±105,66SD	cm/sec	in	non-AMI	group	(p=0.14).	SMA	EDV	mean	velocity	was	 44±24,8SD	 cm/sec	 and	 40,4±27,4cm/sec	 in	 AMI	 and	 non-AMI	 group	respectively	 (p=0.73).	RI	mean	was	0,78±0,12	and	0,79±0,07	 in	AMI	and	non-AMI	group	respectively(p=0.83).			(see	figure	9-10-11)																
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Figure	9.	Comparison	of	SMA	PSV	velocities	between	AMI	and	non-AMI	group 
Figure	10.	Comparison	of	SMA	EDV	velocities	between	AMI	and	non-AMI	group 
Figure	11.	Comparison	of	SMA	RI	ratio	between	AMI	and	non-AMI	group 
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MVT	was	detected	in	both	cases,	one	with	isolated	complete	portal	vein	thrombosis	and	 the	 other	 one	 with	 portal	 and	 superior	 mesenteric	 vein	 filling	 defect	 due	 to	thrombosis	then	confirmed	by	abdomen	CTA.	Bowel	wall	alterations	were	found	in	5/8	(63%)	patients	with	AMI	(four	related	to	small	 intestine	 and	 one	 at	 the	 level	 of	 descending	 colon)	 and	 in	 11/27	 (41%)	without	AMI.		Altered	SMA	PSV	 (value	<80	or	>200cm/sec)	were	present	 in	all	 of	 the	eight	AMI	patients	 and	 in	 15/27(55,6%)	 without	 AMI	 showing	 a	 sensitivity,	 specificity,	positive	 and	 negative	 predictive	 value	 of	 100%,	 44,44%,	 34,78%	 and	 100%	respectively(p=0.02).	SMA	altered	EDV	and	IR	didn’t	show	a	significant	correlation	with	AMI	(p=	0.82	and	0.86	respectively).	AMI-score	 diagnostic	 accuracy	 boosted	 with	 SMA	 PSV	 altered	 value,	 to	 which	 3	points	were	 assigned	 as	ODDs	 ratio	was	1.53	 (95%	CI	 1.13-2.06),	 are	 reported	 in	Table	5	and	ROC	curve	in	figure	12.			Table	5.	AMI-score	and	AMI-score	plus	DUS	diagnostic	accuracy	for	AMI	
AMI-score	validation	
	 AUC	 95%	CI	 Sensitivity	 Specificity	 P	value	
For	OMI-
NOMI	
0.76	 0.83-1	 91%	 35%	 0.015	
For	MVT	 0.90	 0.80-1	 100%	 62%	 0.039	
AMI-score+DUS	alteration	
	 AUC	 95%	CI	 Sensitivity	 Specificity	 P	value	
For	OMI-
NOMI	
0.81	 0.59-1	 100%	 49%	 0.017	
For	MVT	 0.92	 0.80-1	 100%	 51%	 0.047		
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Figure	12.	ROC	curve	of	AMI-score	boosted	with	altered	SMA	PSV	at	DUS 
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Discussion	With	 this	prospective	validation	study	we	 tried	 to	verify	 the	usefulness	of	a	novel	diagnostic	 scoring	 system	 to	 assess	 patients	 presenting	 to	 the	 Emergency	Department	 for	 abdominal	 pain	 of	 unknown	 origin	 suspected	 of	 having	 acute	mesenteric	ischemia.	From	the	previous	restrospective	study	we	created	the	AMI-score	consisting	of	six	items	plus	two	items	for	each	OMI-NOMI	or	MVT	query.	The	score	was	based	on	a	multivariate	regression	analysis	of	patients	investigated	for	AMI.	From	that	analysis,	the	 AMI-score	 result	 >4	 was	 found	 to	 have	 for	 OMI-NOMI	 91.2%	 and	 47.5%	 of	sensitivity	and	specificity	respectively	and	for	MVT	88%	and	56%	of	sensitivity	and	specificity	respectively.	In	this	pilot	validation	study,	AMI-score	confirmed	a	good	overall	accuracy	for	OMI-NIMO(AUC	 was	 0.73	 and	 0.76	 in	 the	 retrospective	 and	 prospective	 study	respectively)	 and	 performed	 even	 better	 for	MVT	 (AUC	was	 0.77	 and	 0.90	 in	 the	retrospective	and	prospective	study	respectively).	Wang	et	al.	proposed	a	novel	scoring	system	for	AMI	based	just	on	laboratory	tests	(RDW,	WBC,	MPV	and	D-dimer)	with	optimal	diagnostic	accuracy	(sensitivity	97.8%,	specificity	91.8%,	PPV	89.8,	NPV	98.2,	LR+	11.93,	LR-00.2).	 80		 In	our	study,	 it	was	impossible	 to	 apply	 that	 score	 as,	 during	 the	 investigation	 period,	 our	 laboratory	was	 not	 allowed	 	 to	 measure	 MPV	 values	 in	 emergency	 for	 a	 specific	 spending	review	 policy.	 Moreover	 in	 that	 study	 they	 excluded	 patients	 with	 chronic	 liver	diseases,	 chronic	 renal	 diseases,	 hematological	 diseases	 and	 who	 was	 receiving	immunosuppressive	 therapy	 because	 of	 altered	 blood	 count	 test.	 That	 population	seems	 too	 selected	 when	 compared	 to	 the	 general	 population	 presenting	 to	 the	
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Emergency	Department,	therefore	that	score	is	weighted	by	poor	generalizability.98	AMI	was	found	in	8/37	(21%)	of	our	population,	an	higher	rate	than	that	reported	in	literature	attested	around	1/1000	admission	for	abdominal	pain.	3,5	However	our	population	study	was	demanding	as	per	inclusion	criteria	because	obvious	causes	of		abdominal	pain	didn’t	entered	the	study.	Moreover	the	overall	presence	of	AMI	may	be	underestimated	as	many	studies	found	it	more	frequently	that	expected	if	sought	properly.	 29	 Rozycki	 et	 al.	 found	 53/300	 (18%)	 AMI	 among	 people	 undergone	emergency	laparotomy	for	acute	abdomen	of	unknown	origin	and	Kärkkäinen	et	al.	found	that	AMI	is	more	common	in	patients	with	age>75yo	than	acute	appendicitis	or	rupture	of	abdominal	aortic	aneurism.	2,99			Regarding		AMI	aetiology,	we	found	an	higher	rate	of	NOMI	than	OMI	(50%	vs	25%)	differently	from	what	is	reported	in	literature.	1,5	In	our	series	8/37	patients	didn’t	received	 contrast	 media	 and	 two	 of	 them	 were	 diagnosed	 with	 NOMI.	 In	 these	patients	the	main	vessels	were	not	evaluated	so	that	a	proper	diagnosis	of	OMI	was	difficult	to	make.	In	recent	years,	new	radiological	MDCT	techniques	are	improving	their	 capacity	 to	 assess	 the	 mesenteric	 vessels	 even	 without	 contrast	 media,	unfortunately	we	don’t	have	this	possibility	in	our	center.	100		Adverse	outcomes	and	mortality	rate	at	3-months	were	more	common	in	AMI	than	non-AMI	population	(25%	vs	17%	and	50%vs6,9%	respectively)	confirming	a	poor	prognosis	 for	 the	 ischemic	 disease.8,101	In	 our	 series	 none	 of	 the	 OMI	 patients	underwent	 endovascular	 treatment	 because	 of	 the	 decision	 of	 the	 interventionist	radiology.	This	trend	seems	to	confirm	that,	despite	the	increasing	utilization	of	new	reperfusion	 treatment	 such	 endovascular	 thrombectomy	 and	 stent	 application,	mortality	remains	high.	9,	102	Although	new	diagnostic	and	treatment	technology	are	
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available,	early	diagnosis	and	reperfusion	strategies	are	the	milestones	to	reach	for	better	prognosis.	50,53	Diagnostic	 DUS	 was	 achievable	 in	 95%	 of	 our	 series	 confirming	 that	 SMA	 is	accessible	 to	 ultrasound.	103	Even	 though	 most	 of	 the	 studies	 about	 DUS	 of	 the	mesenteric	 vessels	 are	made	 in	 non-acute	 setting,	 it	 showed	 good	 feasibility	 and	reproducibility.	66,68	DUS	seems	also	feasible	in	a	ED	contest	as	mean	execution	time	was	 less	 than	 five	 minutes.	 The	 main	 restriction	 was	 related	 to	 the	 presence	 of	experienced	sonographer	being	able	to	perform	it.		Even	 if	 not	 statistically	 significant,	 the	 mean	 of	 SMA	 PSV	 was	 higher	 in	 the	 AMI	group	 than	 non-AMI	 (279,1cm/sec	 vs	 188,7	 cm/sec),	 suggesting	 the	 presence	 of	arterial	 stenosis.	Moneta	 et	 al.	 suggested	a	 cut-off	 of	 275	 cm/sec	or	 greater	or	no	flow	to	as	indicator	of	SMA	stenosis	>70%	and	this	was	confirmed	in	our	population.	
104.	 Furthermore	 SMA	EDV	mean	velocities	 of	 44	 cm/sec	 in	AMI	 group	 correlates,	according	with	Abu	Rahma	et	al.	findings,	with	a	stenosis	of	50%.	However	a	proper	comparison	with	 those	studies	 cannot	be	made	as	 they	used	prepared	and	 fasting	patients	 for	 ultrasound	 whilst	 in	 our	 series	 it	 wasn’t	 possible	 to	 wait	 for	 a	preparation.	RI	values	were	similar	in	both	AMI	and	non-AMI	population.	This	may	suggest	a	little	role	of	RI	alteration	in	AMI	diagnosis.	Ripolles	et	al.	found	similar	RI	values	higher	that	0.60	in	both	patients	with	and	without	ischemic	colitis	.	105	MVT	was	detected	in	both	of	two	cases	presented	giving	a	very	good	sensitivity	and	even	 specificity.	 Both	 of	 them	had	 chronic	 liver	 disease	 so	 that	 clinical	 suspicious	was	 high.	 Portal	 vein	 showed	 a	 very	 good	 accessibility	 to	 DUS	 and	 it’s	 role	 is	relevant.	106	As	superior	mesenteric	vein	is	more	difficult	to	assess	than	portal	vein,	
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Bradbury	 et	 al.	 suggested	 the	 use	 of	 US	 compatible	 intravascular	 contrast	 agents	that	were	not	considered	in	this	study.	107		Bowel	alterations	were	present	at	DUS	 in	63%	of	AMI	compared	 to	41%	non-AMI	group.	However	these	findings	have	more	likely	a	prognostic	meaning	other	than	a	diagnostic	one.108	As	we	reported	earlier,	the	most	specific	bowel	alterations	of	DUS	for	AMI	are	intramural	gas,	portal	system	gas	and	reduced	color	or	power	mode	of	the	 bowel	 walls	 but	 are	 not	 easy	 to	 detect.	 76	 Thus	 duplex	 evaluation	 of	 the	mesenteric	vessels	 can	be	considered	a	better	way	 than	 	bowel	wall	evaluation	 to	investigate	patients	querying	AMI.	109	Altered	SMA	PSV	value	confirmed	to	be	strongly	related	to	AMI	as	expressed	by	the	high	 sensitivity	 and	NPV	 of	 100%,	 remarkably	 none	 of	 AMI	 patient	 had	 a	 normal	SMA	PSV.	This	 finding	seems	to	confirm	previous	data	 from	a	pilot	study	reported	by	 Sartini	 et	 al.	 who	 investigated	 DUS	 alteration	 of	 CA	 and	 SMA	 in	 patients	 with	known	cardiovascular	disease.66	Differently	from	that	study,	 in	our	series	SMA	PSV	was	more	sensitive	(100%	vs	66%)	and	less	specific	(44,4%	versus	63%)	for	NOMI.	It	is	difficult	to	find	an	exhaustive	explanation	for	these	differences,	nonetheless	we	could	 argue	 that	 our	 population	 was	 less	 selective	 as	 they	 included	 just	 patients	with	 known	 cardiovascular	 disease.	 Therefore	 in	 a	more	 homogenous	 population	could	 me	 more	 difficult	 to	 find	 significant	 differences	 other	 than	 in	 a	undifferentiated	population	like	ours.	This	was	the	only	study	we	could	find	about	SMA	evaluation	with	DUS	in	acute	setting.	LIMITATIONS	This	 study	 has	many	 limitations.	 First	 of	 all,	 sample	 size	was	 not	wide	 enough	 to	give	a	sufficient	power	for	generalization.	To	obtain	a	power	of	the	study	of	80%,	we	
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estimated	 a	 sample	 size	 of	 at	 least	 150	 patients	 that	 we	 weren’t	 able	 to	 achieve	during	study	period.	A	possible	explanation	of	having	recruited	less	than	expected,		is	linked	to	the	availability	of	the	sonographer.	As	he	was	the	only	one	in	charge	for	DUS,	if	we	would	have	not	been	able	to	perform	DUS	within	6	hours	from	admission,	a	 potentially	 eligible	 patient	 would	 have	 not	 been	 enrolled	 in	 the	 study.	 The	restriction	 of	 having	 just	 one	 sonographer	 didn’t	 allow	 us	 to	 perform	 an	 inter-observer	analysis	about	DUS	evaluation.	Finally	bowel	evaluation	with	DUS	was	not	systematic	 and	 celiac	 axis	 and	 inferior	mesenteric	 artery	were	not	 evaluated	with	DUS,	that	data	could	have	contribute	to	a	more	complete	assessment	of	DUS.	
Conclusions	AMI	 is	 a	 time-dependent	 life-threatening	 condition	 in	 which	 early	 diagnosis	 and	treatment	 are	mandatory	 to	 reduce	mortality.	 High	 clinical	 suspicion	 is	 often	 the	only	way	 to	 suspect	AMI	among	patients	presenting	with	acute	abdominal	pain	of	unknown	origin.	Abdominal	CT	angiography	is	the	imaging	of	choice,	however	other	pre-test	 tool	 to	 support	 the	physician	 in	 this	 difficult	 diagnosis	 have	not	 been	 yet	identified.	 	 This	 prospective	 study	 validates	 a	 new	 clinical	 diagnostic	 tool,	 the	 so	called	AMI-score,	 to	 support	 physicians	 in	 the	diagnosis	 of	AMI	with	 good	overall	accuracy.	Furthermore	SMA	PSV	alone	at	DUS	can	 increase	 the	sensitivity	 for	AMI	and	a	normal	value	can	rule	it	out.	Unfortunately	the	sample	size	was	limited	so	that	further,	wider	studies	are	needed	 to	both	confirm	the	usefulness	of	 the	AMI-score	and	of	DUS.					
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